Ryan Maynard - Nov 12, 2024 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Director
Signature
/s/ Ryan Maynard
Stock symbol
IOVA
Transactions as of
Nov 12, 2024
Transactions value $
-$130,500
Form type
4
Date filed
11/14/2024, 05:00 PM
Previous filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Options Exercise $373K +50K +666.67% $7.45 57.5K Nov 12, 2024 Direct F1
transaction IOVA Common Stock Sale -$503K -50K -86.96% $10.06 7.5K Nov 12, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOVA Stock Option (right to buy) Options Exercise $0 -50K -100% $0.00 0 Nov 12, 2024 Common Stock 50K $7.45 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an exercise of stock options prior to the 10-year expiration date of such options.
F2 Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
F3 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $10.05 and $10.105.
F4 These options became exercisable in four equal quarterly installments of 12,500 each following the date of grant, which was February 16, 2015.
F5 Such aggregate number reflects the remainder of such stock options granted on February 16, 2015, but does not include any other stock options held by such Reporting Person.